Moreover, Ahn et al. suggested that CD11b-neutralizing antibodies enhanced tumour responsiveness to radiation in transplanted tumours, whereas depletion of Gr-1+ cells did not show the same effect. This evidence concerns the gene ITGAM and neoplasm.